MedPath

Shock Wave Therapy for Lateral Hip Pain, Caused by Tendon Pathology

Not Applicable
Completed
Conditions
Tendinopathy
Interventions
Procedure: focused shock wave therapy
Procedure: ultrasound therapy
Registration Number
NCT03142971
Lead Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Brief Summary

The aim of this randomized controlled study is to investigate if focal shock wave is an effective treatment, with respect to hip pain and lower limb function, in a population affected by greater trochanteric pain syndrome with gluteal tendinopathy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • duration of lateral hip pain of six weeks or longer,
  • normal passive hip range of movement (ROM),
  • sonographic evidence of gluteal tendinopathy at their insertional site at the greater trochanter
Exclusion Criteria
  • general contraindication to extracorporeal shock wave therapy (pacemaker, pregnancy, bleeding disorders or anticoagulant drug usage, cancer in the focal area),
  • history of rheumatologic disease,
  • previous fractures or surgery in the affected limb,
  • full thickness tear of the gluteal tendons,
  • osteoarthritis of the hip (with ROM limitation),
  • clinical signs of lumbar radiculopathy,
  • corticosteroid injections or other conservative therapies (except pharmacological pain treatments) since the onset of the current pain episode.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention:f-ESWT (focused shock wave therapy)focused shock wave therapyIn the study-group, a device powered by a piezoelectric generator (PIEZOSON 100PLUS, Richard Wolf) was used . At the beginning of each treatment session, the enthesis of the gluteal tendons at the greater trochanter (at the anterior half of its lateral facet) was targeted through a non-inline sonographic focusing, using a linear probe (7.5-12 MHz) connected to an ultrasound scanner (ESAOTE MYLAB FIVE, Genova and Florence, Italy). All patients received 1800 pulses (frequency=4Hz) of an energy flux density of 0.15 mJ/mm2 once a week for three consecutive weeks. At the first treatment session, the energy flux density was gradually increased from 0.05 to 0.15 mJ/mm2 during the first 500 pulses.
Intervention:UST (ultrasound therapy)ultrasound therapyIn the control-group, we used a mono-frequency device (ROLAND, RT-20 series, frequency=1MHz). We treated an area of 5cm2, softly moving the US-probe around the most painful point of the greater trochanter at the clinical palpation. UST was supplied in a continuous modality, with an intensity of 1.5 W/cm2, for ten consecutive daily sessions of ten minutes each.
Primary Outcome Measures
NameTimeMethod
LEFS scoreBaseline, at two months, at six months

Change from baseline LEFS (Lower extremity functional scale) total score at 2 months and at 6 months

p-NRSBaseline, at two months, at six months

Change from baseline p-NRS (pain-on-movement numeric rating scale) at 2 months and at 6 months.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath